Viatris Inc.

Viatris Inc. is a global healthcare company dedicated to improving access to high-quality medicines and promoting sustainable operations. Formed through the merger of Mylan and Upjohn, a division of Pfizer, Viatris specializes in manufacturing and distributing prescription generic and branded drugs, over-the-counter products, and complex active pharmaceutical ingredients. The company's extensive portfolio spans therapeutic areas such as cardiovascular, diabetes, infectious diseases, oncology, and women's health. With operations touching over 165 countries and territories, Viatris aims to address evolving patient needs worldwide. Viatris plays a significant role in the healthcare sector by focusing on stability and delivering affordable medication at scale. The company's integrated business model seeks to bridge the gap between innovative and generic treatments, ensuring that critical therapies remain accessible and affordable. Moreover, Viatris's commitment to sustainability and social responsibility resonates with ethical investment frameworks. Emphasizing partnerships and strategic collaborations, Viatris continues to influence the pharmaceutical landscape and expand its global footprint, becoming an important player in the pursuit of accessible healthcare solutions.